Graham K. Cooper
2008 - Orexigen Therapeutics
In 2008, Graham K. Cooper earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at Orexigen Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $158,840 |
|---|---|
| Option Awards | $683,705 |
| Salary | $288,800 |
| Other | $43,975 |
| Total | $1,175,320 |
Cooper received $683.7K in option awards, accounting for 58% of the total pay in 2008.
Cooper also received $158.8K in bonus, $288.8K in salary and $44K in other compensation.
Rankings
In 2008, Graham K. Cooper's compensation ranked 3,882nd out of 9,135 executives tracked by ExecPay. In other words, Cooper earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,882 out of 9,135 | 58th |
Division Manufacturing | 1,393 out of 3,436 | 60th |
Major group Chemicals And Allied Products | 261 out of 815 | 68th |
Industry group Drugs | 154 out of 597 | 74th |
Industry Pharmaceutical Preparations | 114 out of 408 | 72nd |
Source: SEC filing on April 27, 2011.
Cooper's colleagues
We found two more compensation records of executives who worked with Graham K. Cooper at Orexigen Therapeutics in 2008.